Olaposi Yomade

Jena, TH, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

Therapeutic effect of T-cell engager in two patients with autoimmune neuropathy.

Therapeutic effect of T-cell engager in two patients with autoimmune neuropathy.

Journal: Nature communications

Published: October 30, 2025

Correction to: Azacitidine in combination with shortened venetoclax treatment cycles in patients with acute myeloid leukemia.

Correction to: Azacitidine in combination with shortened venetoclax treatment cycles in patients with acute myeloid leukemia.

Journal: Annals of hematology

Published: November 19, 2024

Azacitidine in combination with shortened venetoclax treatment cycles in patients with acute myeloid leukemia.

Azacitidine in combination with shortened venetoclax treatment cycles in patients with acute myeloid leukemia.

Journal: Annals of hematology

Published: August 18, 2024

Chronic hepatitis E virus-induced spinal cord atrophy in a patient with chronic lymphatic leukemia: a case report and interdisciplinary management proposal.

Chronic hepatitis E virus-induced spinal cord atrophy in a patient with chronic lymphatic leukemia: a case report and interdisciplinary management proposal.

Journal: Frontiers in immunology

Published: June 08, 2024

Mutations in the plasma cell clone identify mechanism of polyneuropathy in a case of POEMS syndrome associated with Castleman disease and multiple myeloma.

Mutations in the plasma cell clone identify mechanism of polyneuropathy in a case of POEMS syndrome associated with Castleman disease and multiple myeloma.

Journal: Annals of hematology

Published: September 17, 2022

Sex-Disaggregated Analysis of Biology, Treatment Tolerability, and Outcome of Multiple Myeloma in a German Cohort.

Sex-Disaggregated Analysis of Biology, Treatment Tolerability, and Outcome of Multiple Myeloma in a German Cohort.

Journal: Oncology research and treatment

Published: May 25, 2022

Impact of treatment intensity on infectious complications in patients with acute myeloid leukemia.

Impact of treatment intensity on infectious complications in patients with acute myeloid leukemia.

Journal: Journal of cancer research and clinical oncology

Published: February 21, 2022

Melphalan 200 mg/m2 does not increase toxicity and improves survival in comparison to reduced doses of melphalan in multiple myeloma patients.

Melphalan 200 mg/m2 does not increase toxicity and improves survival in comparison to reduced doses of melphalan in multiple myeloma patients.

Journal: Bone marrow transplantation

Published: July 19, 2020

The risk of infections in multiple myeloma before and after the advent of novel agents: a 12-year survey.

The risk of infections in multiple myeloma before and after the advent of novel agents: a 12-year survey.

Journal: Annals of hematology

Published: November 26, 2018

Dysphagia at Neutropenia of Unknown Primary

Dysphagia at Neutropenia of Unknown Primary

Journal: Laryngo- rhino- otologie

Published: November 17, 2016

Polymorphisms of Toll-like receptors (TLR2 and TLR4) are associated with the risk of infectious complications in acute myeloid leukemia.

Polymorphisms of Toll-like receptors (TLR2 and TLR4) are associated with the risk of infectious complications in acute myeloid leukemia.

Journal: Genes and immunity

Published: September 01, 2014

Impact of NOD2 polymorphisms on infectious complications following chemotherapy in patients with acute myeloid leukaemia.

Impact of NOD2 polymorphisms on infectious complications following chemotherapy in patients with acute myeloid leukaemia.

Journal: Annals of hematology

Published: October 09, 2012

Showing 1-12 of 12

Last Updated: 09/26/2026